Trials / Completed
CompletedNCT04964180
Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Hospitals, Qena, Egypt in period between May 2020 to May 2021.eighty patients was scheduled to elective laparoscopic cholecystectomy , divided Into two groups randomly using closed envelop method. Group IP lidocaine(40 patients ) received 200 ml saline containing 200 mg 2%lidocaine immediately after abdominal cO2 insufflation( pneumoperitoneum) the surgeon sprayed the total solution on the upper surface of the liver under the right subdiaphragmatic space, left subdiaphragmatic space and around the cholecystectomy site , all patients were maintained in trendelenberg position. At the end of the laparoscopic procedure, group indomethacin (40 patients) recived two 100 mg indomethacin rectal suppositories 2 hours prior to surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indomethacin suppository | two 100 mg indomethacin rectal suppositories 2 hours prior to surgery |
| DRUG | Lidocaine 2% Injectable Solution | 200 ml saline containing 200 mg 2%lidocaine intraperitoneal insilltation |
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2021-05-30
- Completion
- 2021-06-20
- First posted
- 2021-07-15
- Last updated
- 2021-07-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04964180. Inclusion in this directory is not an endorsement.